2 years ago

Lindus Health Raises €16.5 Million to Speed Up Clinical Trials with AI

  • Lindus Health, a London and US-based startup, has secured €16.5 million in Series A funding led by Creandum, with participation from Peter Thiel and existing investors

  • The funding will be used to scale up Lindus Health's technology platform, which utilizes machine learning to accelerate clinical trials for conditions like depression, diabetes, and insomnia

  • The company aims to deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly

  • Lindus Health has already delivered over 80 clinical trials across the US, UK, and Europe and is launching trials for treatments for menopause, tinnitus, insomnia, and childhood myopia.

      • ProblemHealthcare

      "Clinical trials are the biggest bottleneck to improving human health. They are slow and expensive, taking years to complete and costing millions of dollars. This means that new treatments take a long time to reach patients, and many people suffer from chronic illnesses that could be treated more effectively."

      Solution

      "Lindus Health is using machine learning to automate and speed up the clinical trial process. This allows them to run trials three times faster than the industry standard, and at a lower cost. This means that new treatments can reach patients more quickly, and people can get the care they need sooner."

      Covered on